• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JTS2400018 利拉鲁肽 liraglutide Active ingredient Biological Products Disposable Import Drug Application 2024-03-14 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
CXSS2400132 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2024-12-03 ChongQing Chenan Biopharmaceutical Co Ltd view
CXSL2200411 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2022-08-29 Tonghua Dongbao Pharmaceutical Co Ltd view
CXHL2300221 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2023-02-15 Zhejiang Heze Pharmaceutical Technology Co Ltd view
CXHS2400103 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2024-10-13 Hybio Pharmaceutical Co Ltd view
JYSZ2300038 利拉鲁肽注射液 liraglutide Injection Biological Products License Renew 2023-09-13 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
CXSS2101024 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2021-09-02 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JYSB2400035 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.1) Supplementary Application 2024-02-27 Novo Nordisk A/S view
CXSS2200065 利拉鲁肽注射液 liraglutide Injection Biological Products(3.2) New Drug Application 2022-07-14 Hangzhou Jiuyuan Genetic Biopharmaceutical Co Ltd;Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd view
JTS2300004 利拉鲁肽二级标准品 liraglutide Active ingredient Biological Products Disposable Import Drug Application 2023-02-14 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
CXSL2400436 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-07-09 Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
CXSS2300067 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2023-08-22 Zhuhai Federal Biomedical Co Ltd;Zhuhai United Laboratories Co Ltd view
CXHL2401290 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2024-11-28 Zhejiang Heze Pharmaceutical Technology Co Ltd view
JTS2100544 利拉鲁肽二级标准品 liraglutide Active ingredient Biological Products Disposable Import Drug Application 2021-11-22 Novo Nordisk (China) Pharmaceuticals Co Ltd;Novo Nordisk A/S view
CXSS2200085 利拉鲁肽注射液 liraglutide Injection Biological Products(3.3) New Drug Application 2022-10-21 Lianyungang Runzhong Pharmaceutical Co Ltd;Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd view
CXSL2400105 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2024-02-07 Tonghua Dongbao Pharmaceutical Co Ltd view
CXSL2300092 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-02-08 The United Bio-Technology(Hengqin) Co Ltd view
CXHL2400487 利拉鲁肽注射液 liraglutide Injection Chemical Drugs(2.2) New Drug Application 2024-05-14 Zhejiang Heze Pharmaceutical Technology Co Ltd view
JYSB2500112 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products Supplementary Application 2025-05-01 Novo Nordisk A/S view
CXSL2300515 德谷胰岛素利拉鲁肽注射液 insulin degludec;liraglutide Injection Biological Products(3.3) New Drug Application 2023-07-26 Jilin Huisheng Biopharmaceutical Co Ltd view